Yim J H, Jeong K H, Shin M K
Department of Dermatology, College of Medicaine, Kyung Hee University, Seoul, Korea.
Skin Res Technol. 2017 May;23(2):169-175. doi: 10.1111/srt.12315. Epub 2016 Aug 11.
BACKGROUND/PURPOSE: Treatment of atopic dermatitis (AD) and psoriasis requires their differentiation from other eczematoid dermatitis and a determination of disease severity. However, both can be clinically difficult and the findings subjectively interpreted. We investigated the utility of in vivo autofluorescence (AF) measurements for diagnosis of both diseases, and determination of severity.
Thirty patients with AD and 30 with psoriasis were recruited, together with sex- and age-matched patients with healthy skin. AF intensity was measured using the EcoSkin fluorescence video dermatoscope. In AD and psoriasis patients, AF in non-sun-exposed lesional and non-lesional skin was measured. To identify the locations that reflect characteristics of AD, AF was also measured at the other sites in the patients with AD.
AD was associated with lower AF and psoriasis with higher AF intensity peaking around 620 nm. In addition, skin AF intensity of each disease was associated with severity of lesion.
Non-invasive measurement of skin AF in vivo can aid in diagnosis of AD and psoriasis as well as in treatment monitoring.
背景/目的:特应性皮炎(AD)和银屑病的治疗需要将它们与其他湿疹样皮炎相鉴别,并确定疾病的严重程度。然而,这两者在临床上都可能具有挑战性,且结果的解读具有主观性。我们研究了体内自体荧光(AF)测量在这两种疾病诊断及严重程度判定中的应用价值。
招募了30例AD患者、30例银屑病患者以及年龄和性别匹配的健康皮肤患者。使用EcoSkin荧光视频皮肤镜测量AF强度。在AD和银屑病患者中,测量非阳光暴露部位的皮损和非皮损皮肤的AF。为了确定反映AD特征的部位,还对AD患者的其他部位进行了AF测量。
AD与较低的AF相关,银屑病与较高的AF强度相关,其峰值在620nm左右。此外,每种疾病的皮肤AF强度与皮损严重程度相关。
体内无创测量皮肤AF有助于AD和银屑病的诊断以及治疗监测。